Browsing by Author "Saygılı, Seha Kamil"
Now showing items 1-3 of 3
-
Cardiometabolic risk factors in pediatric kidney transplant recipients
Saygılı, Seha Kamil; Karabağ Yılmaz, Esra; Kezer, Seçil; Dedeoğlu, Reyhan; Kaplan Kılıç, Şevval; Çiçek, Rümeysa Yasemin; Gülmez, Rüveyda; Demirgan, Ebru Burcu; Ağbaş, Ayşe; Eliçevik, Mehmet; Çalışkan, Salim; Canpolat, Nur (AVES, 2023)Objective: There is an increased risk of obesity and metabolic syndrome among kidney transplant recipients, which adversely affects cardiovascular and renal outcomes in these patients. The present study aims to investigate ... -
Rituximab treatment for difficult-to-treat nephrotic syndrome in children: A multicenter study
Taşdemir, Mehmet; Canpolat, Nur; Yıldız, Nurdan; Özçelik, Gül; Benzer, Meryem; Saygılı, Seha Kamil; Özkayın, Neşe; Türkkan, Özde Nisa; Balat, Ayşe; Candan, Cengiz; Çelakıl, Mehtap Ezel; Yavuz, Sevgi; Akıncı, Nurver; Göknar, Nilüfer; Akgün, Cihangir; Tülpar, Sebahat; Alpay, Harika; Sever, Lale; Bilge, Ilmay (Springer, 2018)… -
Rituximab treatment for difficult-to-treat nephrotic syndrome in children: A multicenter, retrospective study
Taşdemir, Mehmet; Canpolat, Nur; Yıldız, Nurdan; Özçelik, Gül; Benzer, Meryem; Saygılı, Seha Kamil; Özkayın, Emine Neşe; Türkkan, Özde Nisa; Balat, Ayşe; Candan, Cengiz; Çelakıl, Mehtap; Yavuz, Sevgi; Akıncı, Nurver; Göknar, Nilüfer; Akgün, Cihangir; Tülpar, Sebahat; Alpay, Harika; Sever, Fatma Lale; Bilge, İlmay (TÜBİTAK Scientific and Technological Research Council of Turkey, 2021)Background/aim: This study aimed to evaluate the efficacy of rituximab in children with difficult-to-treat nephrotic syndrome, considering the type of disease (steroid-sensitive or -resistant) and the dosing regimen. Materials ...
